http://www.curetoday.com/cure-tv/examining-response-rates-in-msih-and-ntrk-fusion-gi-cancers
Examining Response Rates in MSI-H and NTRK Fusion GI Cancers

Luis A. Diaz, M.D.



Luis A. Diaz, M.D., head of the division of Solid Tumors at Memorial Sloan Kettering Cancer Center, discusses response rates in patients with microsatellite instability-high (MSI-H) or NTRK fusion gastrointestinal (GI) cancers.

Finding these biomarkers in patients with GI cancers can be particularly important, as it can help choose a treatment plan that can have a dramatic response in this group of patients.
Print | cure Printing...